{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-123841","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2023-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.013353+00:00","generated_at":"2026-06-07T16:57:47.513834+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"iBio prices $4.5M public offering of common stock and warrants at $2.00/unit","bullets":["Gross proceeds $4.5M; net proceeds ~$3.6M after fees and expenses.","Offering comprises 2.25M shares (or pre-funded warrants) plus Series C (2-year) and Series D (5-year) warrants.","Series C and D warrants each exercisable for one share at $2.00, immediately exercisable.","Closing expected Dec 7, 2023; proceeds for working capital, R&D, and severance payments.","A.G.P./Alliance Global Partners lead placement agent; Brookline Capital Markets co-placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-123841","json":"https://secwatch.observer/filing/0001104659-23-123841.json","markdown":"https://secwatch.observer/filing/0001104659-23-123841.md","text":"https://secwatch.observer/filing/0001104659-23-123841.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000110465923123841/0001104659-23-123841-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000110465923123841/tm2332212d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:57:47.513834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"572915f690f05399a7989880403765dcbe1ca3af","claim":"iBio, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC valued at 5.5% of the gross proceeds (effective 2023-12-05).","evidence_excerpt":"On December 5, 2023, the Company entered into a placement agency agreement (the “ Placement Agency Agreement ”) with A.G.P./Alliance Global Partners (“ A.G.P. ”), as lead placement agent, and Brookline Capital Markets, a division of Arcadia Securities, LLC (“ Brookline ”), as co-placement agent (A.G.P. and Brookline are referred to herein, collectively, as the “ Placement Agents ”), pursuant to which the Placement Agents agreed to serve as the placement agents for the Company on a “reasonable efforts basis” for the issuance and sale of the Shares and Warrants.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465923123841/0001104659-23-123841-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC"},{"label":"Value","value":"5.5% of the gross proceeds"},{"label":"Effective","value":"2023-12-05"}],"fact_type":"material_agreement"},{"claim_id":"be0b66cf2224f470f9f4c4d93a2665aebe5df649","claim":"iBio, Inc. entered into Purchase Agreement with certain purchaser (the \"Purchasers\") valued at approximately $3.6 million (effective 2023-12-05).","evidence_excerpt":"On December 5, 2023, iBio, Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement with certain purchaser (the “ Purchasers ”) identified on the signature pages thereto (the “ Purchase Agreement ”), pursuant to which the Company agreed to issue and sell, in a public offering (the “ Offering ”), (i) 600,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), (ii) 1,650,000 pre-funded warrants","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465923123841/0001104659-23-123841-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain purchaser (the \"Purchasers\")"},{"label":"Value","value":"approximately $3.6 million"},{"label":"Effective","value":"2023-12-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}